What Types of Generative AI Models Exist Beyond LLMs

LLMs dominate GenAI, but diffusion models, GANs, VAEs, and neural codecs handle image, audio, video, and 3D generation with different architectures.

What Types of Generative AI Models Exist Beyond LLMs
Written by TechnoLynx Published on 22 Apr 2026

The GenAI landscape is wider than LLMs

When organisations say “generative AI,” they usually mean large language models — GPT-4, Claude, Gemini, Llama. This is understandable. LLMs are the most visible, most commercially deployed, and most discussed category of generative model. But the generative AI landscape includes entire families of models that generate images, audio, video, 3D assets, molecular structures, and code — each using architectures that differ fundamentally from the autoregressive token prediction that defines LLMs.

Understanding what exists beyond LLMs matters for two reasons. First, the use case you need to address may be better served by a non-LLM generative model — and defaulting to an LLM for every generative task is like using a hammer for every fastener. Second, the architectural differences between model families have practical implications for deployment: inference cost, latency characteristics, fine-tuning requirements, and output control differ across architectures in ways that affect build decisions.

The Stable Diffusion model processes images in a 64×64 latent space rather than the full 512×512 pixel space, reducing compute requirements by approximately 50× (Rombach et al., 2022). StyleGAN3 (Karras et al., 2021) achieves FID scores below 5 on FFHQ, establishing the quality benchmark for unconditional face generation.

How do diffusion models generate images?

Diffusion models generate images by iteratively denoising a random noise sample. The model learns to reverse a noising process: given a noisy image, predict what the image looked like one step less noisy. Applied iteratively from pure noise, this produces a clean image that matches the model’s learned distribution. Stable Diffusion (Stability AI), DALL-E 3 (OpenAI), Imagen (Google), and Midjourney all use diffusion-based architectures.

How they work. The training process adds Gaussian noise to images at increasing levels, and the model learns to predict and remove the noise at each level. Generation starts from pure noise and applies the denoising prediction repeatedly (typically 20–50 steps) to produce a clean image. Text conditioning (using a text encoder like CLIP or T5 to convert a text prompt into an embedding that guides the denoising) enables text-to-image generation.

Practical characteristics. Inference is iterative — each image requires multiple forward passes through the model, making generation slower than single-pass architectures. A 512×512 image at 50 denoising steps takes 2–10 seconds on a consumer GPU (depending on model size and optimisation). Quality scales with compute: more denoising steps generally produce higher-quality images. Fine-tuning for specific styles or subjects (using techniques like DreamBooth or LoRA) requires 5–50 images of the target subject and produces models that generate that subject consistently.

Where they are used. Marketing and advertising (product visualisation, campaign imagery), entertainment (concept art, game asset generation), e-commerce (product photography replacement, virtual try-on), and design (architecture visualisation, interior design exploration). We have worked with clients who use diffusion models for retail product visualisation and manufacturing documentation illustration.

GANs: adversarial generation with sharp outputs

Generative Adversarial Networks (GANs) train two networks simultaneously: a generator that produces synthetic images, and a discriminator that tries to distinguish synthetic images from real ones. The adversarial training process pushes both networks to improve — the generator produces increasingly realistic images, and the discriminator becomes increasingly discriminating. StyleGAN (NVIDIA), BigGAN, and GigaGAN are prominent examples.

How they differ from diffusion. GANs generate images in a single forward pass — no iterative denoising. This makes generation fast (milliseconds per image). The trade-off: GANs are harder to train (mode collapse, training instability, sensitivity to hyperparameters), less diverse in output (the generator may learn to produce high-quality images from a narrow subset of the distribution), and harder to condition on specific inputs (text-to-image control is less natural than in diffusion models).

Where they remain relevant. Despite diffusion models’ dominance for text-to-image generation, GANs remain the architecture of choice for tasks that require single-pass generation speed: real-time image translation (pix2pix, CycleGAN), super-resolution (ESRGAN), face generation and manipulation (StyleGAN), and data augmentation for training other models. The GAN vs diffusion comparison covers the architectural trade-offs in detail.

VAEs: structured latent spaces for controlled generation

Variational Autoencoders (VAEs) learn a compressed latent representation of the data and generate new samples by decoding points from the latent space. Unlike GANs, VAEs optimise a well-defined probabilistic objective (the evidence lower bound — ELBO), making training stable and reproducible.

How they work. The encoder compresses input data into a distribution in latent space. The decoder generates data from points sampled from this distribution. The latent space is continuous and structured — nearby points in latent space produce similar outputs, enabling smooth interpolation between generated samples and controlled manipulation of output attributes.

Practical characteristics. VAE outputs tend to be smoother and less sharp than GAN or diffusion outputs, because the VAE’s objective includes a reconstruction term that encourages averaging over possibilities. This makes standalone VAEs less suitable for high-fidelity image generation but well-suited for tasks where the latent structure is more important than output sharpness: anomaly detection (outliers have low likelihood in the latent space), data compression, drug discovery (generating molecular structures by sampling the latent space), and representation learning.

In modern architectures. Stable Diffusion uses a VAE as its image encoder/decoder: images are compressed to a latent space by the VAE encoder, the diffusion process operates in this latent space (which is much smaller than pixel space), and the VAE decoder converts the denoised latent back to pixel space. The combination — VAE for compression, diffusion for generation — is more efficient than operating directly in pixel space.

Neural audio and speech models

Generative models for audio span text-to-speech (TTS), music generation, and sound effect synthesis. The architectures differ from image generation:

Autoregressive models (WaveNet, SoundStorm) generate audio sample-by-sample or token-by-token, similar to how LLMs generate text. High quality, but slow inference due to the sequential generation process.

Diffusion models adapted for audio (AudioLDM, Stable Audio) apply the diffusion framework to spectrograms or latent audio representations. Text-to-audio generation follows the same conditioning approach as text-to-image.

Neural codec models (EnCodec by Meta, SoundStream by Google) compress audio into discrete tokens that can be modelled by autoregressive or masked models. This approach powers recent voice cloning and music generation systems — the audio is tokenised, a language model generates new token sequences, and the codec decoder converts tokens back to waveforms.

Video generation models

Video generation extends image generation to the temporal dimension, with additional complexity: temporal consistency (objects must maintain their appearance and physics across frames), motion coherence (movement must be physically plausible), and compute cost (generating 30 frames per second of video requires 30× the computation of a single image).

Current approaches include: diffusion models extended with temporal attention layers (Sora by OpenAI, Runway Gen-2, Stable Video Diffusion), autoregressive video generation (producing frames sequentially with each frame conditioned on the previous), and frame interpolation approaches that generate keyframes and fill in intermediate frames. The technology is advancing rapidly but remains compute-intensive and quality-variable — production-quality video generation at scale is not yet practical for most commercial applications.

3D generation models

3D asset generation — producing 3D meshes, textures, and materials from text or image prompts — is the newest frontier of generative AI. Models like Point-E, Shap-E (OpenAI), and DreamFusion generate 3D representations using various approaches: point cloud generation, neural radiance fields (NeRFs), and score distillation sampling (optimising a 3D representation to match a diffusion model’s learned distribution from multiple viewpoints).

The practical maturity is limited: generated 3D assets typically require significant manual cleanup before they are usable in production pipelines (games, film, industrial design). The technology’s trajectory suggests production-quality 3D generation within 2–3 years.

Choosing the right generative architecture

The architecture choice depends on the output modality and the deployment constraints:

Output Architecture Key trade-off
Text LLM (autoregressive) Quality vs inference cost
Images Diffusion model Quality vs generation speed
Real-time image transforms GAN Speed vs training stability
Structured generation VAE Control vs output sharpness
Audio/speech Neural codec + LM Quality vs latency
Video Temporal diffusion Quality vs compute cost

Defaulting to an LLM for every GenAI use case is a common mistake. If your use case involves image, audio, video, or 3D generation, the appropriate architecture is likely not an LLM — and the deployment characteristics (cost, latency, infrastructure) will differ accordingly.

If your team is evaluating GenAI use cases across multiple modalities, a GenAI Feasibility Assessment maps each use case to the appropriate model architecture and provides deployment cost and capability estimates. Our generative AI practice covers the full spectrum of generative model architectures.

Why Most Enterprise AI Projects Fail — and How to Predict Which Ones Will

Why Most Enterprise AI Projects Fail — and How to Predict Which Ones Will

22/04/2026

Enterprise AI projects fail at 60–80% rates. Failures cluster around data readiness, unclear success criteria, and integration underestimation.

Proven AI Use Cases in Pharmaceutical Manufacturing Today

Proven AI Use Cases in Pharmaceutical Manufacturing Today

22/04/2026

Pharma manufacturing AI is deployable now — process control, visual inspection, deviation triage. The approach is assessment-first, not technology-first.

Why Generative AI Projects Fail Before They Launch

Why Generative AI Projects Fail Before They Launch

21/04/2026

GenAI project failures cluster around scope inflation, evaluation gaps, and integration underestimation. The patterns are predictable and preventable.

How to Evaluate GenAI Use Case Feasibility Before You Build

How to Evaluate GenAI Use Case Feasibility Before You Build

20/04/2026

Most GenAI use cases fail at feasibility, not implementation. Assess data, accuracy tolerance, and integration complexity before building.

Why Off-the-Shelf Computer Vision Models Fail in Production

Why Off-the-Shelf Computer Vision Models Fail in Production

20/04/2026

Off-the-shelf CV models degrade in production due to variable conditions, class imbalance, and throughput demands that benchmarks never test.

Planning GPU Memory for Deep Learning Training

Planning GPU Memory for Deep Learning Training

16/02/2026

GPU memory estimation for deep learning: calculating weight, activation, and gradient buffers so you can predict whether a training run fits before it crashes.

CUDA AI for the Era of AI Reasoning

CUDA AI for the Era of AI Reasoning

11/02/2026

How CUDA underpins AI inference: kernel execution, memory hierarchy, and the software decisions that determine whether a model uses the GPU efficiently or wastes it.

Deep Learning Models for Accurate Object Size Classification

Deep Learning Models for Accurate Object Size Classification

27/01/2026

A clear and practical guide to deep learning models for object size classification, covering feature extraction, model architectures, detection pipelines, and real‑world considerations.

GPU vs TPU vs CPU: Performance and Efficiency Explained

GPU vs TPU vs CPU: Performance and Efficiency Explained

10/01/2026

CPU, GPU, and TPU compared for AI workloads: architecture differences, energy trade-offs, practical pros and cons, and a decision framework for choosing the right accelerator.

AI and Data Analytics in Pharma Innovation

AI and Data Analytics in Pharma Innovation

15/12/2025

Machine learning in pharma: applying biomarker analysis, adverse event prediction, and data pipelines to regulated pharmaceutical research and development workflows.

Validation‑Ready AI for GxP Operations in Pharma

Validation‑Ready AI for GxP Operations in Pharma

19/09/2025

Make AI systems validation‑ready across GxP. GMP, GCP and GLP. Build secure, audit‑ready workflows for data integrity, manufacturing and clinical trials.

Edge Imaging for Reliable Cell and Gene Therapy

Edge Imaging for Reliable Cell and Gene Therapy

17/09/2025

Edge imaging transforms cell & gene therapy manufacturing with real‑time monitoring, risk‑based control and Annex 1 compliance for safer, faster production.

AI Visual Inspection for Sterile Injectables

11/09/2025

Improve quality and safety in sterile injectable manufacturing with AI‑driven visual inspection, real‑time control and cost‑effective compliance.

Predicting Clinical Trial Risks with AI in Real Time

5/09/2025

AI helps pharma teams predict clinical trial risks, side effects, and deviations in real time, improving decisions and protecting human subjects.

Generative AI in Pharma: Compliance and Innovation

1/09/2025

Generative AI transforms pharma by streamlining compliance, drug discovery, and documentation with AI models, GANs, and synthetic training data for safer innovation.

AI for Pharma Compliance: Smarter Quality, Safer Trials

27/08/2025

AI helps pharma teams improve compliance, reduce risk, and manage quality in clinical trials and manufacturing with real-time insights.

Markov Chains in Generative AI Explained

31/03/2025

Discover how Markov chains power Generative AI models, from text generation to computer vision and AR/VR/XR. Explore real-world applications!

Optimising LLMOps: Improvement Beyond Limits!

2/01/2025

LLMOps optimisation: profiling throughput and latency bottlenecks in LLM serving systems and the infrastructure decisions that determine sustainable performance under load.

MLOps for Hospitals - Staff Tracking (Part 2)

9/12/2024

Hospital staff tracking system, Part 2: training the computer vision model, containerising for deployment, setting inference latency targets, and configuring production monitoring.

MLOps for Hospitals - Building a Robust Staff Tracking System (Part 1)

2/12/2024

Building a hospital staff tracking system with computer vision, Part 1: sensor setup, data collection pipeline, and the MLOps environment for training and iteration.

MLOps vs LLMOps: Let’s simplify things

25/11/2024

MLOps and LLMOps compared: why LLM deployment requires different tooling for prompt management, evaluation pipelines, and model drift than classical ML workflows.

Streamlining Sorting and Counting Processes with AI

19/11/2024

Learn how AI aids in sorting and counting with applications in various industries. Get hands-on with code examples for sorting and counting apples based on size and ripeness using instance segmentation and YOLO-World object detection.

Maximising Efficiency with AI Acceleration

21/10/2024

Find out how AI acceleration is transforming industries. Learn about the benefits of software and hardware accelerators and the importance of GPUs, TPUs, FPGAs, and ASICs.

How to use GPU Programming in Machine Learning?

9/07/2024

Learn how to implement and optimise machine learning models using NVIDIA GPUs, CUDA programming, and more. Find out how TechnoLynx can help you adopt this technology effectively.

AI in Pharmaceutics: Automating Meds

28/06/2024

Artificial intelligence is without a doubt a big deal when included in our arsenal in many branches and fields of life sciences, such as neurology, psychology, and diagnostics and screening. In this article, we will see how AI can also be beneficial in the field of pharmaceutics for both pharmacists and consumers. If you want to find out more, keep reading!

Exploring Diffusion Networks

10/06/2024

Diffusion networks explained: the forward noising process, the learned reverse pass, and how these models are trained and used for image generation.

Retrieval Augmented Generation (RAG): Examples and Guidance

23/04/2024

Learn about Retrieval Augmented Generation (RAG), a powerful approach in natural language processing that combines information retrieval and generative AI.

A Gentle Introduction to CoreMLtools

18/04/2024

CoreML and coremltools explained: how to convert trained models to Apple's on-device format and deploy computer vision models in iOS and macOS applications.

Introduction to MLOps

4/04/2024

What MLOps is, why organisations fail to move models from training to production, and the tooling and processes that close the gap between experimentation and deployed systems.

Case-Study: Text-to-Speech Inference Optimisation on Edge (Under NDA)

12/03/2024

See how our team applied a case study approach to build a real-time Kazakh text-to-speech solution using ONNX, deep learning, and different optimisation methods.

Generating New Faces

6/10/2023

With the hype of generative AI, all of us had the urge to build a generative AI application or even needed to integrate it into a web application.

Case-Study: Generative AI for Stock Market Prediction

6/06/2023

Case study on using Generative AI for stock market prediction. Combines sentiment analysis, natural language processing, and large language models to identify trading opportunities in real time.

Generative models in drug discovery

26/04/2023

Traditionally, drug discovery is a slow and expensive process that involves trial and error experimentation.

Back See Blogs
arrow icon